Efferent Labs Taps Evotec to Advance Implantable Biosensor for R&D, Oncology

FierceBiotech Efferent Labs has inked a deal with Evotec to develop its implantable biosensor technology. The device, which is injected…

Efferent Labs Signs Agreement With Evotec AG To Continue Development Of Groundbreaking Medical Diagnostic Product

January 9, 2017 FOR MORE INFORMATION CONTACT: press@efferentlabs.com Download the Press Release